Table 4.
Blood parameter, treatment dose and variability (MSSD) of Period 1–2 vs. Period 3–4, C.E.R.A
| C.E.R.A. |
Period 1–2 |
Period 3–4 |
p-value |
|---|---|---|---|
| (n = 19) | (n = 19) | ||
|
Hemoglobin, g/dl (mean, SD) |
11.2 (1.2) |
11.6 (0.7) |
0.16 |
|
Reticulocyte count, cells/μl (mean, SD) |
68367 (17794) |
78916 (20626) |
0.10 |
|
Ferritin, μg/l (mean, SD) |
444.4 (140.9) |
433.1 (105.3) |
0.78 |
|
Cumulated ESA dose, μg (mean, SD) |
950.3 (544.5) |
895 (657.7) |
0.79 |
|
Cumulated iron dose, μg (mean, SD) |
684.2 (285.3) |
712.5 (272.9) |
0.77 |
|
ST-MSSD Hb, g2/dl2 (mean, SD) |
0.56 (0.67) |
0.52 (0.40) |
0.83 |
|
LT-MSSD Hb, g2/dl2 (mean, SD) |
0.64 (0.51) |
1.25 (1.10) |
0.03 |
|
ST-MSSD Ret, cells2/μl2 (mean, SD) |
35.8x108 (29.6x108) |
16.5x108 (14.4x108) |
0.01 |
|
LT-MSSD Ret, cells2/μl2 (mean, SD) |
5.4x108 (7.3x108) |
12.1x108 (15.5x108) |
0.10 |
| LT-MSSD ESA, μg2 (mean, SD) | 10609 (16963) | 29043 (12641) | 0.25 |